J1627 HCPCS code: Injection, granisetron, extended-release, 0.1 mg
J1627 is the HCPCS Level II code for injection, granisetron, extended-release, 0.1 mg. In 2024 Medicare paid an average of $4.37 per service for J1627 across 1,208,808 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 100 per day on outpatient hospital claims. Medicare volume rose 71% from 2022 to 2024 (706,698 to 1,208,808 services). In 2024, about 259 clinicians billed Medicare for J1627 for 2,680 beneficiaries; Kansas, South Carolina, California accounted for 45% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2018-01-01 |
| Last action effective | 2018-01-01 |
Who bills J1627 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 259 |
| Medicare beneficiaries | 2,680 |
| States with claims | 21 |
| Share of services in top 3 states (Kansas, South Carolina, California) | 45% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1627, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 706,698 | 1,863 | $6.25 | $4.99 |
| 2023 | 1,114,432 | 2,570 | $5.88 | $4.68 |
| 2024 | 1,208,808 | 2,680 | $5.48 | $4.37 |
States with the most J1627 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Kansas | 259,700 | $4.39 |
| South Carolina | 140,600 | $4.33 |
| California | 138,440 | $4.33 |
| Oklahoma | 101,700 | $4.38 |
| Florida | 82,232 | $4.35 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 100 | Prescribing Information |
| practitioner claims | 100 | Prescribing Information |
What changed for J1627
- 2018-01-01: J1627 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1627?
J1627 is the HCPCS Level II code for injection, granisetron, extended-release, 0.1 mg. Short descriptor: "Inj, granisetron, xr, 0.1 mg".
How much does Medicare pay for J1627?
In 2024, the average Medicare payment was $4.37 per service (average allowed $5.48).
Does Medicare cover J1627?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1627 can be billed per day?
100 on outpatient hospital claims; 100 on practitioner claims (NCCI medically unlikely edits).
Related J16 codes
- J1600 — Injection, gold sodium thiomalate, up to 50 mg
- J1602 — Injection, golimumab, 1 mg, for intravenous use
- J1610 — Injection, glucagon hydrochloride, per 1 mg
- J1611 — Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- J1612 — Injection, glucagon (gvoke), 0.01 mg
- J1620 — Injection, gonadorelin hydrochloride, per 100 mcg
- J1626 — Injection, granisetron hydrochloride, 100 mcg
- J1628 — Injection, guselkumab, 1 mg
- J1630 — Injection, haloperidol, up to 5 mg
- J1631 — Injection, haloperidol decanoate, per 50 mg
- J1632 — Injection, brexanolone, 1 mg
- J1640 — Injection, hemin, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1627
- Watch J1627 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1627
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.